Literature DB >> 26560171

T cell immunity to dengue virus and implications for vaccine design.

Laura Rivino1.   

Abstract

Dengue virus infections are increasing at an alarming rate in many tropical and subtropical countries and represent, in some of these areas, a leading cause of hospitalization and death among children. The lack of a clear definition of the correlates of protection from severe dengue disease represents a major hurdle for vaccine development. In particular, the role of T lymphocytes during dengue infection remains unclear and there is evidence suggesting that these cells may be important for both protective immunity and/or immunopathology. In this review we discuss the findings that support a protective role of T cells versus those supporting their involvement in pathogenesis. A better understanding of T cell immunity is urgently needed for the development of safe and efficacious vaccines.

Entities:  

Keywords:  DENV; T cell epitopes; T cells; immunopathology; primary infection; protective immunity; secondary infection; vaccines

Mesh:

Substances:

Year:  2015        PMID: 26560171     DOI: 10.1586/14760584.2016.1116948

Source DB:  PubMed          Journal:  Expert Rev Vaccines        ISSN: 1476-0584            Impact factor:   5.217


  19 in total

Review 1.  Transcriptomic immune profiles of human flavivirus-specific T-cell responses.

Authors:  Alba Grifoni; Yuan Tian; Alessandro Sette; Daniela Weiskopf
Journal:  Immunology       Date:  2020-01-07       Impact factor: 7.397

Review 2.  CD4+ and CD8+ T-cell immunity to Dengue - lessons for the study of Zika virus.

Authors:  Laura Rivino; Mei Qiu Lim
Journal:  Immunology       Date:  2016-11-27       Impact factor: 7.397

3.  Longitudinal Analysis of Dengue Virus-Specific Memory T Cell Responses and Their Association With Clinical Outcome in Subsequent DENV Infection.

Authors:  Luis Alberto Sanchez-Vargas; Kathryn B Anderson; Anon Srikiatkhachorn; Jeffrey R Currier; Heather Friberg; Timothy P Endy; Stefan Fernandez; Anuja Mathew; Alan L Rothman
Journal:  Front Immunol       Date:  2021-07-28       Impact factor: 8.786

4.  Transcriptomics of Acute DENV-Specific CD8+ T Cells Does Not Support Qualitative Differences as Drivers of Disease Severity.

Authors:  Alba Grifoni; Hannah Voic; Esther Dawen Yu; Jose Mateus; Kai Mei Yan Fung; Alice Wang; Grégory Seumois; Aruna D De Silva; Rashika Tennekon; Sunil Premawansa; Gayani Premawansa; Rashmi Tippalagama; Ananda Wijewickrama; Ashu Chawla; Jason Greenbaum; Bjoern Peters; Vijayanand Pandurangan; Daniela Weiskopf; Alessandro Sette
Journal:  Vaccines (Basel)       Date:  2022-04-14

Review 5.  Innate immune receptors drive dengue virus immune activation and disease.

Authors:  Joris Sprokholt; Leanne C Helgers; Teunis Bh Geijtenbeek
Journal:  Future Virol       Date:  2017-11-17       Impact factor: 1.831

6.  Human T cell responses to Dengue and Zika virus infection compared to Dengue/Zika coinfection.

Authors:  Jessica Badolato-Corrêa; Juan Camilo Sánchez-Arcila; Thiara Manuele Alves de Souza; Luciana Santos Barbosa; Priscila Conrado Guerra Nunes; Monique da Rocha Queiroz Lima; Mariana Gandini; Ana Maria Bispo de Filippis; Rivaldo Venâncio da Cunha; Elzinandes Leal de Azeredo; Luzia Maria de-Oliveira-Pinto
Journal:  Immun Inflamm Dis       Date:  2017-12-28

Review 7.  Development of Peptide Vaccines in Dengue.

Authors:  Kavita Reginald; Yanqi Chan; Magdalena Plebanski; Chit Laa Poh
Journal:  Curr Pharm Des       Date:  2018       Impact factor: 3.116

8.  Global Assessment of Dengue Virus-Specific CD4+ T Cell Responses in Dengue-Endemic Areas.

Authors:  Alba Grifoni; Michael A Angelo; Benjamin Lopez; Patrick H O'Rourke; John Sidney; Cristhiam Cerpas; Angel Balmaseda; Cassia G T Silveira; Alvino Maestri; Priscilla R Costa; Anna P Durbin; Sean A Diehl; Elizabeth Phillips; Simon Mallal; Aruna D De Silva; Godwin Nchinda; Celine Nkenfou; Matthew H Collins; Aravinda M de Silva; Mei Qiu Lim; Paul A Macary; Filippo Tatullo; Tom Solomon; Vijaya Satchidanandam; Anita Desai; Vasanthapram Ravi; Josefina Coloma; Lance Turtle; Laura Rivino; Esper G Kallas; Bjoern Peters; Eva Harris; Alessandro Sette; Daniela Weiskopf
Journal:  Front Immunol       Date:  2017-10-13       Impact factor: 7.561

9.  Cross-Reactivity and Anti-viral Function of Dengue Capsid and NS3-Specific Memory T Cells Toward Zika Virus.

Authors:  Mei Qiu Lim; Emmanuelle A P Kumaran; Hwee Cheng Tan; David C Lye; Yee Sin Leo; Eng Eong Ooi; Paul A MacAry; Antonio Bertoletti; Laura Rivino
Journal:  Front Immunol       Date:  2018-10-01       Impact factor: 7.561

Review 10.  Immune Responses to Dengue and Zika Viruses-Guidance for T Cell Vaccine Development.

Authors:  Claude Roth; Félix G Delgado; Etienne Simon-Lorière; Anavaj Sakuntabhai
Journal:  Int J Environ Res Public Health       Date:  2018-02-23       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.